Management of Recurrent Post-Viral Wheezing in Children

Introduction to Asthma Prevention and Treatment

The American Academy of Allergy, Asthma, and Immunology recommends that inhaled salbutamol is a short-acting beta-agonist used for symptom relief only—it does not modify disease progression or prevent asthma development 1, 2
Inhaled corticosteroids are the only medication class proven to provide long-term control and reduce morbidity in children with persistent wheezing, not short-acting beta-agonists like salbutamol 1, 2, 3

The American Thoracic Society suggests that asthma should NOT be diagnosed based on symptoms alone—objective testing is required when age-appropriate 4
Other conditions that can present identically to asthma include gastroesophageal reflux disease, sleep-disordered breathing, protracted bacterial bronchitis, and less commonly cystic fibrosis, foreign body aspiration, or congenital heart disease 1, 2, 5

The American Academy of Pediatrics recommends that low-dose inhaled corticosteroids are the preferred treatment for mild persistent asthma in children, with budesonide nebulizer solution FDA-approved for children 1-8 years of age 1, 3
If initiating a therapeutic trial of inhaled corticosteroids, monitor carefully and stop treatment if no clear benefit is seen within 4-6 weeks 3

The natural history of viral-triggered wheezing in young children is highly variable, and no reliable markers exist to predict which children will have symptom resolution versus persistent asthma 1
Approximately 50-80% of children with asthma develop symptoms before age 5, but not all early wheezers develop persistent asthma 1

Look for variable expiratory airflow limitation and symptoms that vary over time and intensity, including daytime symptoms, and consider spirometry with bronchodilator response if the child is age-appropriate 5, 4
Assess for atopic features, such as eczema, food allergies, and family history of asthma 1

The American College of Chest Physicians recommends that children with chronic cough (more than 4 weeks) after viral bronchiolitis should not be treated with asthma medications unless there are other symptoms of asthma, such as recurrent wheezing and/or shortness of breath 6, 7, 8
For children with recurrent wheezing (more than 3 episodes in the previous year) and risk factors for persistent asthma, long-term treatment may be considered 6, 7, 8
The European Respiratory Society notes that recurrent wheezing is the most important symptom of asthma, not isolated cough 9
Children with chronic cough (more than 4 weeks) as the only symptom are unlikely to have asthma 9

Approximately 90% of children with viral bronchiolitis are cough-free by day 21 6

The European Respiratory Society recommends that children should be evaluated for signs of true asthma before starting treatment, including recurrent wheezing and atopic features such as eczema, food allergy, and family history of asthma 9

The American Academy of Allergy, Asthma, and Immunology recommends avoiding the term "reactive airway disease" as it delays proper asthma diagnosis and treatment in children with recurrent wheezing, resulting in missed opportunities to reduce morbidity 10

The European Respiratory Society defines asthma as a disease that includes symptoms of wheeze, cough, and breathing difficulty together with reversible airways obstruction, airway inflammation, and bronchial hyperresponsiveness 11
Recurrent wheeze is the most important symptom of asthma, and children with this symptom should undergo further evaluation for asthma 11
Children with chronic cough as the only symptom are unlikely to have asthma and should be investigated according to chronic cough guidelines 11

The presence of atopic features, family history of asthma, and more than 3 wheezing episodes in the previous year are risk factors for persistent asthma, although specific details such as lab values are not provided 12
Symptoms triggered by viral infections, exercise, allergens, or cold air can indicate asthma, and a thorough medical history is necessary to determine the presence of these symptoms 12

For children under 5 years, the term "suspected asthma" or "probable asthma" should be used when recurrent wheezing is present with risk factors, and treatment should be guided by clinical judgment and guidelines from reputable medical societies 10
For children 5 years and older, objective testing with spirometry and bronchodilator reversibility should be pursued to diagnose asthma, and treatment should be based on symptoms, pulmonary function, and medication requirements 11, 12